Takeda Pharmaceutical Co Ltd (TAK) insider trading

Every open-market stock purchase and sale by Takeda Pharmaceutical Co Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Andrew Stewart Plump (President) and 12 others sold $13.1M in the last 90 days.
  • No open-market insider buys on record.

Last 12 months: insiders bought $0 (0 buys) and sold $13.1M (19 sales). Last close $19.93 on Oct 21, 2026.

Recent TAK insider trades

DateInsiderTradeValue
Sep 14, 2026Lauren Rusckowski Duprey (C-suite exec)Sold$640K
Sep 2, 2026Andrew Stewart Plump (President)Sold$2.1M
Aug 19, 2026Andrew Stewart Plump (President)Sold$363K
Aug 18, 2026Nicola Deidre Petal Greenway (Officer)Sold$235K
Aug 11, 2026Elaine Mary Shannon (Officer)Sold$357K
Aug 10, 2026Andrew Stewart Plump (President)Sold$2.8M
Aug 10, 2026Julie So-Young Kim (CEO)Sold$1.5M
Aug 10, 2026Teresa Marie Bitetti (President)Sold$855K
Aug 10, 2026Lauren Rusckowski Duprey (C-suite exec)Sold$814K
Aug 10, 2026Nicola Deidre Petal Greenway (Officer)Sold$589K
Aug 10, 2026Giles Richard Platford (President)Sold$532K
Aug 10, 2026Natalie Anne Marie Furney (General Counsel)Sold$528K
Aug 10, 2026Gabriele Ricci (Officer)Sold$429K
Aug 10, 2026Agosti Marcello Pignagnoli (Officer)Sold$393K
Aug 10, 2026Rhonda Janice Pacheco (President)Sold$289K
Aug 10, 2026Awny Samaan Botros Farajallah (C-suite exec)Sold$240K
Aug 10, 2026Ramy Riad Ahmed Ibrahim (President)Sold$124K
Aug 10, 2026Nicola Deidre Petal Greenway (Officer)Sold$116K
Aug 10, 2026Elaine Mary Shannon (Officer)Sold$68K
Aug 10, 2026Nicola Deidre Petal Greenway (Officer)Sold$17.1K
Jul 10, 2026Milano Furuta (CFO)Sold (not open market)$82M
Jul 10, 2026Miki Tsusaka (Director)Sold (not open market)$10.6M
Jul 10, 2026Masami Iijima (Director)Sold (not open market)$10.6M
Jul 10, 2026Kimberly A. Reed (Director)Sold (not open market)$5.7M
Jul 10, 2026Steven Gillis (Director)Sold (not open market)$5.7M

Who's trading TAK

Get free alerts when an insider at Takeda Pharmaceutical Co Ltd files a new trade →